propiconazole has been researched along with Smoking Cessation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Eckstein, A; Führer, D; Möller, L; Oeverhaus, M | 1 |
| Berta, A; Boda, J; Burman, KD; Galuska, L; Kollar, J; Leovey, A; Nagy, EV; Szabo, J; Szucs-Farkas, Z; Toth, J; Ujhelyi, B; Varga, J | 1 |
| Ammann-Rauch, D; Breuer, T; Tasman, AJ | 1 |
1 review(s) available for propiconazole and Smoking Cessation
| Article | Year |
|---|---|
[Graves' orbitopathy].
Topics: Administration, Intravenous; Antibodies, Monoclonal, Humanized; Antioxidants; Decompression, Surgical; Graves Ophthalmopathy; Humans; Lubricant Eye Drops; Orbit; Receptor, IGF Type 1; Risk Factors; Selenium; Smoking Cessation; Steroids | 2021 |
2 other study(ies) available for propiconazole and Smoking Cessation
| Article | Year |
|---|---|
Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.
Topics: Adult; Aged; Connective Tissue; Female; Graves Disease; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oculomotor Muscles; Orbit; Smoking; Smoking Cessation | 2005 |
[Treatment of difficult endocrine orbitopathy cases].
Topics: Adult; Aged; Blindness; Decompression, Surgical; Exophthalmos; Female; Follow-Up Studies; Graves Disease; Graves Ophthalmopathy; Humans; Orbit; Recurrence; Risk Factors; Smoking; Smoking Cessation; Thyroidectomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vision, Ocular | 2007 |